Researchers from Tufts Medical Center have launched a large multi-center randomized control trial, in attempt to see if vitamin D can help prevent type 2 diabetes.
The study, named D2d, is sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and funded by the National Institutes for Health (NIH). It is the first large study to examine if vitamin D supplements can help prevent or delay type 2 diabetes in adults with prediabetes. While there have been some similar studies in the past, those studies have been small with few participants.
This is the second diabetes and vitamin D study out of Tufts of late. Earlier this year, Tufts started recruiting for another vitamin D-diabetes study, a study to examine how vitamin D supplements affect how the body processes glucose.
The D2d study will last for 4 years and will enroll approximately 2,500 participants. Researchers are seeking adults 30 years or older who have prediabetes or are at risk of developing diabetes.
“Vitamin D use has risen sharply in the U.S. in the last 15 years, since it has been suggested as a remedy for a variety of conditions,” says study manager, Dr Myrlene Staten. “But we need rigorous testing to determine if vitamin D will help prevent diabetes.”
There are over 20 centers throughout the United States recruiting patients for this study. If you are interested in enrolling, see if you’re eligible and how to sign up by visiting the D2d website at http://www.d2dstudy.org/.